-
Deine Einschätzung
Was spricht für und gegen Advanced Proteome Therapeutics in den nächsten Jahren?
Pro
Kontra
Rendite von Advanced Proteome Therapeutics im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | -1,72 % | 83,20 % | 51,66 % | 68,38 % | 37,95 % | -21,03 % | -67,52 % |
| Vaxart Inc. | 0,00 % | 27,91 % | 12,24 % | 15,69 % | 96,43 % | -29,49 % | -90,68 % |
| Celldex Therapeutics | -0,78 % | 29,29 % | 15,32 % | 29,95 % | 16,36 % | -40,02 % | 14,08 % |
News
How Much Higher Will Micron Stock Go in 2026?
Broadly speaking, investing in semiconductor stocks has been a wise choice over the last year. As artificial intelligence (AI) hyperscalers double down on infrastructure budgets, the need to secure
Worried About a Decline in Stocks? This Magnificent Index Fund Could Turn $300 Per Month into $1 Million.
Investors have piled into growth stocks, particularly those involved in artificial intelligence (AI), over the past three years, and that's driven the S&P 500 higher -- in fact, the index increased
IonQ Just Delivered the Quarter That Changes the Quantum Narrative
Wall Street was caught off guard on Thursday, Feb. 26, as shares of IonQ (NYSE: IONQ) rallied, climbing over 19% to break the $40 psychological barrier. The rise in IonQ’s share price follows the


